EVONA SMITH: Open Payments
NPI 1265769327 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$847 in 31 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $847
Food & beverage: $847
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 8 | $336 |
| Novo Nordisk Inc | 4 | $82 |
| Regeneron Healthcare Solutions, Inc. | 2 | $51 |
| Dexcom, Inc. | 2 | $47 |
| Xeris Pharmaceuticals, Inc. | 2 | $44 |
| Janssen Biotech, Inc. | 2 | $42 |
| PharmaEssentia USA Corporation | 1 | $33 |
| Astellas Pharma US Inc | 1 | $27 |
| Madrigal Pharmaceuticals | 1 | $26 |
| Merck Sharp & Dohme LLC | 1 | $26 |
Products named: Korlym, Ozempic, LIBTAYO, Dexcom G6 Transmitter, BESREMI, Vyloy, REZDIFFRA, REBLOZYL.
Industry payments across LA — which companies pay providers there.
